** = Publikationen gelistet in SCI/SSCI/Pubmed
** Arzt, L; Kothmaier, H; Halbwedl, I; Quehenberger, F; Popper, HH
Signal transducer and activator of transcription 1 (STAT1) acts like an oncogene in malignant pleural mesothelioma.
Virchows Arch. 2014; 465(1):79-88
Doi: 10.1007/s00428-014-1584-8
Web of Science
PubMed
FullText
FullText_MUG
** Kothmaier, H; Popper, HH
Proteomics? Reply
ARCH PATHOL LAB MED. 2012; 136(3): 237-237.
Doi: 10.5858/arpa.2011-0506-LE
[OPEN ACCESS]
Web of Science
PubMed
FullText
FullText_MUG
** Kothmaier, H; Popper, HH
Formalin Fixation Reply
Arch Pathol Lab Med. 2012; 136(2): 137-138.
Doi: 10.5858/arpa.2011-0423-LE
[OPEN ACCESS]
Web of Science
PubMed
FullText
FullText_MUG
** Arzt, L; Kothmaier, H; Quehenberger, F; Halbwedl, I; Wagner, K; Maierhofer, T; Popper, HH
Evaluation of formalin-free tissue fixation for RNA and microRNA studies.
Exp Mol Pathol. 2011; 91(2):490-495
Doi: 10.1016/j.yexmp.2011.05.007
Web of Science
PubMed
FullText
FullText_MUG
Google Scholar
** Kothmaier, H; Rohrer, D; Stacher, E; Quehenberger, F; Becker, KF; Popper, HH
Comparison of formalin-free tissue fixatives: a proteomic study testing their application for routine pathology and research.
Arch Pathol Lab Med. 2011; 135(6): 744-752.
Doi: 10.5858/2009-0676-OA.1
[OPEN ACCESS]
Web of Science
PubMed
FullText
FullText_MUG
Google Scholar
** Bonin, S; Hlubek, F; Benhattar, J; Denkert, C; Dietel, M; Fernandez, PL; Höfler, G; Kothmaier, H; Kruslin, B; Mazzanti, CM; Perren, A; Popper, H; Scarpa, A; Soares, P; Stanta, G; Groenen, PJ
Multicentre validation study of nucleic acids extraction from FFPE tissues.
Virchows Arch. 2010; 457(3): 309-317.
Doi: 10.1007/s00428-010-0917-5
[OPEN ACCESS]
Web of Science
PubMed
FullText
FullText_MUG
Google Scholar
** Kothmaier, H; Faoro, V; Daniele, L; Zamo, A; Rossoni, R; Schott, C; Bussolati, G; Stanta, G; Popper, HH; Becker, KF
Impacts: planning a European initiative for standardized protein analysis of archival clinical tissues
VIRCHOWS ARCHIV. 2009; 455: 23-23.
[Oral Communication]
Web of Science
** Dacic, S; Kothmaier, H; Land, S; Shuai, Y; Halbwedl, I; Morbini, P; Murer, B; Comin, C; Galateau-Salle, F; Demirag, F; Zeren, H; Attanoos, R; Gibbs, A; Cagle, P; Popper, H
Prognostic significance of p16/cdkn2a loss in pleural malignant mesotheliomas.
Virchows Arch. 2008; 453(6): 627-635.
Doi: 10.1007/s00428-008-0689-3
Web of Science
PubMed
FullText
FullText_MUG
Google Scholar
** Kothmaier, H; Quehenberger, F; Halbwedl, I; Morbini, P; Demirag, F; Zeren, H; Comin, CE; Murer, B; Cagle, PT; Attanoos, R; Gibbs, AR; Gallateau-Salle, F; Popper, HH
EGFR and PDGFR differentially promote growth in malignant epithelioid mesothelioma of short and long term survivors.
Thorax. 2008; 63(4):345-351
Doi: 10.1136/thx.2007.085241
[OPEN ACCESS]
Web of Science
PubMed
FullText
FullText_MUG
Google Scholar
** Allen, TC; Popper, HH; Kothmaier, H; Halbwedl, I; Morbini, P; Murer, B; Comin, CE; Galateau-Salle, F; Demirag, F; Zeren, H; Attanoos, R; Gibbs, A; Cagle, PT
Osteopontin (OPN) and HIF-1 expression in diffuse malignant mesothelioma (DMM) with long-term (> 3Year) survival (LS) versus short-term survival (SS)
MODERN PATHOL. 2008; 21: 335A-335A.
[Poster]
Web of Science
** Allen, TC; Popper, HH; Kothmaier, H; Halbwedl, I; Morbini, P; Murer, B; Comin, CE; Galateau-Salle, F; Demirag, F; Zeren, H; Attanoos, R; Gibbs, A; Cagle, PT
Osteopontin (OPN) and HIF-1 expression in diffuse malignant mesothelioma (DMM) with long-term (> 3Year) survival (LS) versus short-term survival (SS)
LAB INVEST. 2008; 88: 335A-335A.
[Poster]
Web of Science
** Dacic, S; Poppei, HH; Kothmaier, H; Halbwedt, I; Morbini, P; Murer, B; Comin, CE; Galateau-Salle, F; Demirag, F; Zeren, H; Allanoos, R; Gibbs, A; Cagle, PT
Prognostic significance of p16/CDKN2A deletion in pleural mesotheliomas
MODERN PATHOL. 2008; 21: 339A-340A.
[Poster]
Web of Science
** Dacic, S; Popper, HH; Kothmaier, H; Halbwedl, I; Morbini, P; Murer, B; Comin, CE; Galateau-Salle, F; Demirag, F; Zeren, H; Attanoos, R; Gibbs, A; Cagle, PT
Prognostic significance of p16/CDKN2A deletion in pleural mesotheliomas
LAB INVEST. 2008; 88: 339A-340A.
[Poster]
Web of Science
** Kothmaier, H; Becker, KF; Schott, C; Popper, HH
STAT1 activation in malignant pleural mesothelioma in formalin-fixed and paraffin-embedded tissue using protein lysate microarrays.
HISTOPATHOLOGY. 2008; 53: 808--27th International Congress of the International-Academy-of-Pathology; OCT 12-17, 2008; Athens, GREECE.
[Poster]
Web of Science
** Kothmaier, H; Rohrer, D; Halbwedl, I; Popper, HH
Comparison of three commercially, non-crosslinking fixatives: A proteomic study testing their application for routine and research.
HISTOPATHOLOGY. Histopathology Suppl.12008; 53: 685-299.-27th International Congress of the International-Academy-of-Pathology; OCT 12-17, 2008; Athens, GREECE.
[Poster]
Web of Science
** Popper, HH; Kothmaier, H
Proteomics-Tissue and Protein Microarrays and Antibody Array What Information Is Provided?
ARCH PATHOL LAB MED. 2008; 132(10):1570-1572.-21st European Congress of Pathology; SEP 08-13, 2007; Istanbul, TURKEY.
Doi: 10.5858/2008-132-1570-PAPMAA
[Oral Communication]
[OPEN ACCESS]
Web of Science
PubMed
FullText
FullText_MUG
Google Scholar
** Kothmaier, HE; Quehenberger, F; Halbwedl, I; Popper, HH
Favored signaling pathways in short- and long-term survivors of pleural mesothelioma.
FASEB J. 2007; 21(5):A383-A383.-Experimental Biology Meeting; APR 28-2 MAI, 2007; Washington DC, USA.
[Oral Communication]
Web of Science
** Blaukovitsch, M; Halbwedl, I; Kothmaier, H; Gogg-Kammerer, M; Popper, HH
Sarcomatoid carcinomas of the lung--are these histogenetically heterogeneous tumors?
Virchows Arch. 2006; 449(4):455-461
Doi: 10.1007/s00428-006-0256-8
[Oral Communication]
Web of Science
PubMed
FullText
FullText_MUG
** Kothmaier, HE; Ingolic, E; Popper, HH
Human malignant pleura mesothelioma - a three-dimensional (3D) tumor model
FASEB J. 20: A216-A216.-Experimental Biology 2006 Meeting; APR 01-05, 2006; San Francisco,CA, USA.
[Poster]
Web of Science
** Kothmaier, H; Petzmann, S; Halbwedl, I; Popper, HH
Gene silencing of PCNA in mesothelioma cell lines causes deregulation of other genes
LAB INVEST. 2005; 85: 313A-313A.-94th Annual Meeting of the United-States-and-Canadian-Academy-of-Pathology; FEB 26-MAR 04, 2005; San Antonio, USA.
Web of Science
** Kothmaier, H; Petzmann, S; Halbwedl, I; Popper, HH
Gene silencing of PCNA in mesothelioma cell lines causes deregulation of other genes
MODERN PATHOL. 2005; 18: 313A-313A.-94th Annual Meeting of the United-States-and-Canadian-Academy-of-Pathology; FEB 26-MAR 04, 2005; San Antonio, USA.
Web of Science